5XSU
novel orally efficacious inhibitors complexed with PARP1
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | SSRF BEAMLINE BL17U1 |
| Synchrotron site | SSRF |
| Beamline | BL17U1 |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2015-12-14 |
| Detector | ADSC QUANTUM 315r |
| Wavelength(s) | 0.9791 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 103.670, 107.270, 142.540 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 48.714 - 2.400 |
| R-factor | 0.2227 |
| Rwork | 0.221 |
| R-free | 0.27410 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 4hhy |
| RMSD bond length | 0.008 |
| RMSD bond angle | 1.017 |
| Data reduction software | XDS |
| Data scaling software | XSCALE |
| Phasing software | PHASER |
| Refinement software | PHENIX |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 48.714 | 48.714 | 2.460 |
| High resolution limit [Å] | 2.400 | 10.730 | 2.400 |
| Rmerge | 0.072 | 0.034 | 0.530 |
| Rmeas | 0.084 | 0.040 | 0.617 |
| Total number of observations | 463165 | ||
| Number of reflections | 120032 | 1323 | 8885 |
| <I/σ(I)> | 13.6 | 35.19 | 2.83 |
| Completeness [%] | 100.0 | 98.4 | 100 |
| Redundancy | 3.859 | 3.766 | 3.862 |
| CC(1/2) | 0.998 | 0.998 | 0.775 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, HANGING DROP | 8 | 293 | 0.1M Tris pH 7.5, 1% PEG400, 2.1M (NH4)2SO4 |






